The further Western blot assay confirmed that the treatment with rIGF-1 enhanced the spinal p-IGF1R level in T1DM mice (Figure 4(e), P = 0.0067, n = 5). This evidence concerns the gene IGF1R and type 1 diabetes mellitus.